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Public health, pandemic response, and the 2020 US election
From a health perspective, the upcoming US election 
could be the most consequential in our lifetimes. Before 
the COVID-19 pandemic, the USA already had a modest 
standing across many global health measures: among 
11 industrialised nations, the USA ranked last in life 
expectancy and highest in suicide rates, had among 
the highest number of hospitalisations for preventable 
causes, and had the highest rate of avoidable death.1 
Moreover, the USA has the highest numbers of 
uninsured people in the developed world: one in four 
individuals report foregoing care because of out-of-
pocket costs, even if they are insured, and one in four 
do not take needed drugs because of prescription costs.2 
Fatal opioid overdoses nearly doubled between 2010 
and 2018, from 38 000 to 67 000 deaths.3 Existing 
health disparities include a life expectancy for Black 
Americans 3·5 years lower than for white Americans; 
for Native Americans, life expectancy is 5·5 years lower.4 
People from ethnic minority populations receive 
worse care than do white Americans for chronic non-
communicable diseases such as kidney disease5 and 
cardiovascular disease,6 and inequalities in treatment 
are seen for those who are pregnant and for children.7 
Furthermore, the USA has underinvested in public 
health initiatives such as local, county, and state public 
health assistance, global and emerging infectious 
disease programmes, and the Strategic National 
Stockpile.8 The budget for the US Centers for Disease 
Control and Prevention (CDC) has fallen by 10% over 
the past decade,9 adjusting for inflation, and the budget 
for the Health Services and Research Administration 
is US$10·7 billion,10 which is a tiny amount compared 
with the $3·6 trillion spent on health-care expenditures 
nationally. 
With the arrival of the COVID-19 pandemic, the 
already dire situation with respect to health outcomes 
and inequities will worsen without urgent course 
correction. Since January, 2020, the US Government has 
fumbled on testing, contact tracing, social distancing, 
face masks, and hospital supply; it has failed to lean 
on scientific leaders to manage the crisis; and it has 
not provided consistent, coordinated evidence-based 
messaging for the public. This response would have 
been terrible under any circumstance, but combined 
with complacent co-existence with an increasingly 
penetrable public health and health-care system, the 
USA has entered a perfect storm, the threat from which 
has universal reach. 
The COVID-19 pandemic has shined an unflattering 
light on every flaw in the US health-care system: 
disparate social determinants, chronic disease burden, 
and limited health-care access; a fragile safety net; 
astronomical costs of care; and system complexity, 
misaligned incentives, and disjointed communication. 
Further, the pandemic has shown how problems outside 
the traditional health-care system intersect with our 
health: too many Americans cannot afford rent; too 
many children go hungry and are falling behind at 
school (to the extent school is even happening); and 
workforce segregation and a childcare crisis have left too 
many people without options for staying solvent and 
staying safe from COVID-19.
The USA has underperformed globally in its pandemic 
response but still has unparalleled resources and 
potential. It is not too late to mitigate the effect of 
the current crisis. Any plan needs to invest massively 
in testing, contact tracing, and support for Americans 
if further shelter-in-place orders are needed. Such a 
plan needs to be rooted in science, present a capable 
and coordinated government response, and show a 
fundamental understanding: what happens to our most 
vulnerable, marginalised communities dictates the 
success of the whole country.
The next US administration and Congress not only 
need to solve this current crisis but also put in place 
safeguards to prevent it from happening again. In the 
short term, thoughtful detailed proposals are needed to 
describe how we might enhance the Affordable Care Act 
to shore up health-care coverage, bolster the Prevention 
and Public Health Fund, and address key weaknesses 
of the US health-care system, including the absence 
of cost transparency and the staggering expense of 
pharmaceutical drugs. Health equity considerations need 
to be embedded in all public policies; priorities need to be 
set; and presidential and congressional candidates should 
be honest and realistic about what can be achieved and by 
when, and what the tradeoffs might be—in a headcount 
of American lives—for each decision.
There are, roughly, two choices for the 2020 
candidates. Either they can deny the effect of the 
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COVID-19 pandemic, and both the immediate failures 
and structural forces that let it play out so disastrously 
in the USA, or they can accept that we need change and 
articulate a real plan for it. The USA can achieve global 
health excellence, but leadership is needed to guide the 
country away from counterproductive assumptions of 
US exceptionalism, recognising with humility where 
we fall short and where we have much to learn from 
countries that fare better in health outcomes, both 
before and in COVID times. We need to start rebuilding 
with a solid framework, one capable of sheltering every 
American individual’s health and one that will stand 
strong through the next global health crisis. 
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